Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease

NCT00141960 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux

Interventions

DRUG: Famotidine

Sponsor

Astellas Pharma Inc